¼¼°èÀÇ ¹é½Å º¸°ü ¼³ºñ ½ÃÀå
Vaccine Storage Equipment
»óǰÄÚµå : 1793931
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 390 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,183,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,550,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¹é½Å º¸°ü ¼³ºñ ½ÃÀåÀº 2030³â±îÁö 13¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 11¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ¹é½Å º¸°ü ¼³ºñ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 3.8%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 13¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ÄÝµå ¹Ú½º´Â CAGR 3.1%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 3¾ï 5,320¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ¼Ò¸ðǰ¡¤ºÎ¼Óǰ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 3.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 2¾ï 9,160¸¸ ´Þ·¯, Áß±¹Àº CAGR 6.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¹é½Å º¸°ü ¼³ºñ ½ÃÀåÀº 2024³â¿¡ 2¾ï 9,160¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 6.9%¸¦ °ßÀÎÇϸç, 2030³â¿¡´Â 2¾ï 6,800¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 1.6%¿Í 2.9%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¹é½Å º¸°ü ¼³ºñ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

½Å·ÚÇÒ ¼ö ÀÖ´Â ¹é½Å º¸°ü ½Ã¼³ÀÌ Àü ¼¼°è ¿¹¹æÁ¢Á¾ ¼º°ø¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¹é½Å º¸°ü ½Ã¼³Àº ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥ÀÇ ±âº» ±¸¼º ¿ä¼Ò·Î, ¹é½ÅÀÌ Á¦Á¶µÈ ÈÄ Åõ¿©µÉ ¶§±îÁö ¹é½ÅÀÇ È¿´É°ú À¯È¿¼ºÀ» À¯ÁöÇϵµ·Ï º¸ÀåÇÕ´Ï´Ù. ¹é½ÅÀº ¸Å¿ì ¹Î°¨ÇÑ »ý¹°Á¦Á¦À̱⠶§¹®¿¡ ¾ö°ÝÇÑ ¿Âµµ °ü¸®°¡ ÇÊ¿äÇϸç, ÀϹÝÀûÀÎ ¹é½ÅÀº 2¡É-8¡É, mRNA ±â¹Ý ¹é½Å°ú °°Àº ƯÁ¤ °í±Þ Á¦Á¦ÀÇ °æ¿ì ´õ ³·Àº ¿Âµµ¿¡¼­ °ü¸®ÇØ¾ß ÇÕ´Ï´Ù. ÀûÀýÇÑ º¸°üÀ» ÇÏÁö ¾ÊÀ¸¸é ¹é½ÅÀÇ È¿´ÉÀÌ »ó½ÇµÇ¾î ¿¹¹æÁ¢Á¾ È¿°ú°¡ ¾ø¾îÁö°Å³ª, Á¢Á¾½Ã À§ÇèÇÑ »óŰ¡ µÉ ¼öµµ ÀÖ½À´Ï´Ù. ´ë±Ô¸ð ¿¹¹æÁ¢Á¾ Ä·ÆäÀÎÀ̳ª ÀÏ»óÀûÀÎ ÀÇ·á ¼­ºñ½º Á¦°ø¿¡¼­ ÄݵåüÀÎ À¯Áö´Â ´Ü¼øÇÑ ¹°·ù ¹®Á¦°¡ ¾Æ´Ï¶ó °øÁß º¸°Ç ¾ÈÀü°ú °ü·ÃµÈ ¹®Á¦ÀÔ´Ï´Ù. µû¶ó¼­ ³ÃÀå°í, ³Ãµ¿°í, ³ÃÀå½Ç, º¸³Ã ¹Ú½º, ¿Âµµ ¸ð´ÏÅ͸µ ÀåÄ¡´Â ÀÇ·á½Ã¼³, ¾à±¹, ¿¬±¸¼¾ÅÍ, À̵¿½Ä ¿¹¹æÁ¢Á¾½Ç µî¿¡¼­ ÇʼöÀûÀ¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. WHO, UNICEF, Gavi µî ¼¼°èº¸°Ç±â±¸´Â ƯÈ÷ ÀÎÇÁ¶ó ¹®Á¦·Î ÀÎÇØ ÄݵåüÀÎÀÇ ¹«°á¼ºÀ» ÇØÄ¥ ¼ö ÀÖ´Â ÁßÀú¼Òµæ ±¹°¡¿¡¼­ ¹é½Å º¸°ü ÀÎÇÁ¶óÀÇ Á߿伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ COVID-19¸¦ °è±â·Î Àü ¼¼°è ¹é½Å Á¢Á¾ Ȱµ¿ÀÌ È°¹ßÇØÁö¸é¼­ ¹é½Å º¸°ü¿¡ ´ëÇÑ °ü½ÉÀÌ ´õ¿í ³ô¾ÆÁ³°í, ÄݵåüÀÎ ½Ã½ºÅÛÀÇ Ç°Áú°ú ÀÌ¿ë ÆíÀǼº Ãø¸é¿¡¼­ °³¼±ÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ÀûÀýÇÑ º¸°üÀº ºÎÆÐ¿Í ±ÝÀüÀû ³¶ºñ¸¦ ¹æÁöÇÒ »Ó¸¸ ¾Æ´Ï¶ó °ø±ÞµÈ ¸ðµç ¿ë·®ÀÌ ÀǵµÇÑ ¿¹¹æ È¿°ú¸¦ ´Þ¼ºÇÒ ¼ö ÀÖµµ·Ï º¸ÀåÇϹǷΠº¸°ü Àåºñ´Â ÇコÄɾî Àü´Þ¸Á¿¡¼­ ¹é½Å ÀÚü¸¸Å­À̳ª Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¹é½Å º¸°ü ½Ã½ºÅÛÀÇ ´É·ÂÀ» ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

¹é½Å º¸°ü ½Ã¼³ÀÇ ÁøÈ­´Â ¿Âµµ Á¶Àý, µ¥ÀÌÅÍ ¸ð´ÏÅ͸µ, ¿¡³ÊÁö È¿À², Àç·á ¼³°èÀÇ ¹ßÀü¿¡ Å« ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÃֽŠ½Ã½ºÅÛ¿¡´Â µðÁöÅÐ ¿Âµµ Á¶Àý±â, ÀÚµ¿ Á¦»ó »çÀÌŬ, ÆäÀÏ ¼¼ÀÌÇÁ ¾Ë¶÷ÀÌ ³»ÀåµÇ¾î ÀÖÀ¸¸ç, Á¤È®Çϰí Áß´Ü ¾ø´Â ¿Âµµ Á¦¾î¸¦ ½ÇÇöÇÕ´Ï´Ù. °¡Àå ÁÖ¸ñÇÒ ¸¸ÇÑ °³¹ß Áß Çϳª´Â ¼¾¼­¿Í Ŭ¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀ» »ç¿ëÇÏ¿© º¸°ü »óŰ¡ ±ÔÁ¤µÈ ¹üÀ§¿¡¼­ ¹þ¾î³¯ °æ¿ì ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ½Ç½Ã°£À¸·Î °æ°í¸¦ º¸³»´Â ¿¬¼Ó ¿Âµµ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀ» ÅëÇÕÇÑ °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â´ÉÀ» ÅëÇØ ¼öÀÛ¾÷ Á¡°Ë¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ÁÙÀ̰í ÀáÀçÀûÀÎ Àåºñ °íÀå¿¡ ´ëÇÑ ½Å¼ÓÇÑ ´ëÀÀÀÌ °¡´ÉÇÕ´Ï´Ù. ¿Üµý Áö¿ªÀ̳ª ºñÀü±âÈ­ Áö¿ª¿¡¼­´Â ž翭 ³ÃÀå°í¿Í ¹èÅ͸®·Î ±¸µ¿µÇ´Â Äݵå¹Ú½º°¡ ¿­¾ÇÇÑ Á¶°Ç¿¡¼­µµ ¾ÈÁ¤ÀûÀÎ º¸°üÀ» °¡´ÉÇÏ°Ô ÇÏ¿© Å« º¯È­¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. ´õ¿í ÁøÈ­µÈ ȯ°æ¿¡¼­´Â -80¡ÉÀÇ Àú¿ÂÀ» À¯ÁöÇÒ ¼ö ÀÖ´Â ÃÊÀú¿Â(ULT) ³Ãµ¿±â°¡ mRNA ¹é½Å°ú Â÷¼¼´ë »ý¹°Á¦Á¦ °³¹ßÀ» µ½°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹é½Å¿ë ³ÃÀå°í´Â Á¶Àý °¡´ÉÇÑ ¼±¹Ý, º¸¾ÈÀ» À§ÇÑ Àá±Ý½Ä µµ¾î, À§»ý ±âÁØÀ» Áö¿øÇÏ´Â Ç×±Õ ÀÎÅ׸®¾î µî »ç¿ëÇϱ⠽¬¿î ±â´ÉÀ» °®Ãá µðÀÚÀÎÀ¸·Î ¼³°èµÇ°í ÀÖ½À´Ï´Ù. ´Ü¿­Àç¿Í ¾ÐÃà±â È¿À²ÀÇ Çõ½ÅÀº ¿¡³ÊÁö ¼Òºñ¸¦ ÁÙÀÌ°í ¹é½Å º¸Á¸ ¼Ö·ç¼ÇÀÇ Áö¼Ó°¡´É¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº ¼º´É°ú ½Å·Ú¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó, ÀÇ·á ½Ã½ºÅÛÀÌ º¸´Ù È¿À²ÀûÀ̰í ÀûÀº ÀÚ¿øÀ¸·Î È®ÀåµÈ ¿¹¹æÁ¢Á¾ ¸ñÇ¥¸¦ ´Þ¼ºÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù.

¹é½Å º¸°ü Àåºñ ¼ö¿ä¸¦ ÁÖµµÇÏ´Â ¼¼°è ½ÃÀå°ú ÀÌ¿ë »ç·Ê´Â?

¹é½Å º¸°ü ½Ã¼³¿¡ ´ëÇÑ ¼ö¿ä´Â ÷´Ü ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥À» º¸À¯ÇÑ °í¼Òµæ ±¹°¡¿Í ¹é½Å Á¢±Ù¼º È®´ë¿¡ Èû¾²°í ÀÖ´Â Àú¼Òµæ ±¹°¡¸¦ ¸··ÐÇϰí Àü ¼¼°è¿¡¼­ ´Ù¾çÇÑ ÇコÄɾî ȯ°æ¿¡¼­ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì¿Í À¯·´¿¡¼­´Â ÃÊÀú¿ÂÀ» ÇÊ¿ä·Î ÇÏ´Â ¹é½ÅÀ» Æ÷ÇÔÇÑ »õ·Î¿î ¹é½Å Á¦Á¦ÀÇ µµÀÔ°ú ¹é½Å ¾ÈÀü¿¡ ´ëÇÑ ±ÔÁ¦ °­È­·Î ÀÎÇØ ÷´Ü Àú¿Â º¸°üÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ º´¿ø, ¾à±¹, ´ë±Ô¸ð ÀÇ·á ½Ã½ºÅÛÀº Á¤È®ÇÑ ¿Âµµ Á¦¾î, µ¥ÀÌÅÍ ·Î±ë, ÀÇ·á Á¤º¸ ½Ã½ºÅÛ°úÀÇ ¿¬°áÀ» Á¦°øÇÏ´Â ÃÖ÷´Ü ³ÃÀå Àåºñ¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¹Ý¸é, ¾ÆÇÁ¸®Ä«, ³²¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÀϺΠ±¹°¡¿¡¼­´Â ºÐ»êÇü ÀÇ·á ÀÎÇÁ¶ó¿¡ ÀûÇÕÇÏ°í ³»±¸¼ºÀÌ ¶Ù¾î³ª¸ç À¯Áöº¸¼ö°¡ ¿ëÀÌÇÑ Àú°¡ÀÇ Àåºñ·Î Á¢±Ù¼ºÀ» È®´ëÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ±¹Á¦º¸°Ç±â±¸°¡ ÁÖµµÇÏ´Â ÀÌ ÇÁ·Î±×·¥Àº ³óÃÌ Áø·á¼Ò¿Í À̵¿ Áø·á¼Ò¿¡ ž翭 ³ÃÀå°í¿Í ÈÞ´ë¿ë ³Ã°¢±â¸¦ ¼³Ä¡ÇÏ¿© ¹é½ÅÀÌ ºÎÆÐÇÏÁö ¾Ê°í ÀÇ·á ¼­ºñ½º¸¦ Á¦´ë·Î ¹ÞÁö ¸øÇÏ´Â »ç¶÷µé¿¡°Ô Àü´ÞµÉ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼Ò¸Å ¾à±¹ ¹× ¿¹¹æÁ¢Á¾ Ŭ¸®´ÐÀÇ ±Þ°ÝÇÑ ¼ºÀåÀ¸·Î ÀÎÇØ °ø°£À» Àý¾àÇÏ°í ¾ÈÁ¤ÀûÀ¸·Î ÀÛµ¿ÇÏ´Â ¼ÒÇü Ź»ó¿ë ¹é½Å º¸°üÇÔ¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼öÀÇÇÐ ¹× ¿¬±¸ ºÐ¾ßµµ Áß¿äÇÑ ¼ÒºñÀÚÀ̸ç, µ¿¹°¿ë ¹é½Å ¹× ¿¬±¸¿ë »ùÇÃÀ» ¾ö°ÝÇÑ Á¶°Ç¿¡¼­ ¾ÈÀüÇÏ°Ô º¸°üÇØ¾ß ÇÕ´Ï´Ù. µ¶°¨ ¿¹¹æÁ¢Á¾, ¿©Çà¿ë ÀǾàǰ, Çб³ ¿¹¹æÁ¢Á¾°ú °°Àº °èÀýº° Ä·ÆäÀÎÀº À¯¿¬Çϰí È®Àå °¡´ÉÇÑ ½ºÅ丮Áö ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ´Ù¾çÇÑ ÀÌ¿ë »ç·Ê´Â ºÐ¾ß¿Í Áö¿ªÀ» ºÒ¹®ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ¹é½Å º¸°ü ½Ã¼³¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä¸¦ Áö¼ÓÀûÀ¸·Î Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

¹é½Å º¸°ü Àåºñ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?

¹é½Å º¸°ü Àåºñ ½ÃÀåÀÇ ¼ºÀåÀº ¼¼°è ¿¹¹æÁ¢Á¾ ³ë·Â, ±ÔÁ¦ Áؼö ¿ä°Ç, ±â¼ú Çõ½Å, ÄݵåüÀÎ ½Å·Ú¼º¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀÎÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. °¡Àå Å« ¿øµ¿·Â Áß Çϳª´Â ±¹°¡Àû ¿¹¹æÁ¢Á¾ ÇÁ·Î±×·¥ÀÇ È®´ë¿Í ¹é½ÅÀ¸·Î ¿¹¹æ °¡´ÉÇÑ Áúº´À» ÅðÄ¡Çϱâ À§ÇÑ ¼¼°è Ä·ÆäÀÎÀ̸ç, ÀÌ·Î ÀÎÇØ ¾ÈÀüÇϰí È®Àå °¡´ÉÇÑ ½ºÅ丮Áö ¼Ö·ç¼Ç¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ ¼ö¿ä°¡ ¹ß»ýÇϰí ÀÖ½À´Ï´Ù. COVID-19¸¦ °è±â·Î ¹é½Å °³¹ß ¹× À¯ÅëÀÌ °¡¼ÓÈ­µÇ¸é¼­ ÄݵåüÀÎ ÀÎÇÁ¶óÀÇ ½É°¢ÇÑ °ÝÂ÷°¡ µå·¯³µ°í, ÷´Ü Àåºñ¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇÏ´Â °è±â°¡ µÇ¾ú½À´Ï´Ù. Àü ¼¼°è ±ÔÁ¦±â°üÀº º¸°ü ¹× ¹®¼­È­ ±âÁØÀ» °­È­Çϰí, ÀÇ·á½Ã¼³¿¡ µðÁöÅÐ ¸ð´ÏÅ͸µ ¹× °æ°í ±â´ÉÀ» °®Ãá È¿°úÀûÀÎ Àåºñ¸¦ µµÀÔÇÒ °ÍÀ» ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¼Ò¿ÜµÈ Áö¿ª¿¡¼­ÀÇ °øÆòÇÑ ¹é½Å ¹èÆ÷¸¦ ÃËÁøÇϱâ À§ÇØ ±¹Á¦ÀûÀÎ ±âºÎÀÚ ¹× ¹Î°ü ÆÄÆ®³Ê½ÊÀÇ Áö¿øÀ» ¹Þ¾Æ Off-grid ¹× À̵¿½Ä º¸°ü ¼Ö·ç¼ÇÀÇ µµÀÔÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿Âµµ¿¡ ¹Î°¨ÇÑ »ý¹°Á¦Á¦ ¹× mRNA ±â¹Ý ¹é½ÅÀÇ °³¹ßÀÌ ÁøÇàµÊ¿¡ µû¶ó º´¿ø, ¿¬±¸¼¾ÅÍ ¹× ¹°·ù ÇÁ·Î¹ÙÀÌ´õ¿¡¼­ ÃÊÀú¿Â º¸°ü ´É·Â¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÇÑÆí, IoT Áö¿ø ¸ð´ÏÅ͸µ, ž籤¹ßÀü ÀåÄ¡, ¿¡³ÊÁö È¿À²ÀÌ ³ôÀº ¾ÐÃà±â µîÀÇ ±â¼ú Çâ»óÀ¸·Î ¹é½Å º¸°ü ¼Ö·ç¼ÇÀÌ ´õ¿í Æí¸®ÇÏ°í ºñ¿ë È¿À²ÀûÀÏ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÇコÄɾîÀÇ µðÁöÅÐÈ­ Ãß¼¼µµ ÇѸòÀ» Çϰí ÀÖÀ¸¸ç, º´¿øµéÀº ÀüÀڰǰ­±â·Ï ¹× Àç°í ½Ã½ºÅÛ°ú ÅëÇÕÇÒ ¼ö ÀÖ´Â Àåºñ¸¦ ¿øÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ °áÇÕµÇ¾î ¼¼°è ¹é½Å º¸°ü Àåºñ ½ÃÀåÀº °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖÀ¸¸ç, ÀÏ»óÀûÀÎ °øÁߺ¸°Ç ´ëÀÀ°ú ºñ»ó½Ã °øÁߺ¸°Ç ´ëÀÀ ¸ðµÎ¿¡ ÇʼöÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(º¸³Ã ¹Ú½º, ¼Ò¸ðǰ¡¤ºÎ¼Óǰ, ¹ßÆ÷ ÆÐµå, ³Ãµ¿°í, °¨½Ã Àåºñ, ³ÃÀå°í, ¹é½Å ij¸®¾î), Á¦Ç° À¯Çü(³ÃÀå º¸°ü, ³ÃÀå ¿î¼Û), ÃÖÁ¾»ç¿ëÀÚ(À¯Åë¾÷ü¡¤¹°·ù ÃÖÁ¾»ç¿ëÀÚ, º´¿ø¡¤ÀÇ·á±â°ü ÃÖÁ¾»ç¿ëÀÚ, ¼Ò¸Å¾÷ü ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Vaccine Storage Equipment Market to Reach US$1.3 Billion by 2030

The global market for Vaccine Storage Equipment estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Cold Boxes, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$353.2 Million by the end of the analysis period. Growth in the Consumables & Accessories segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$291.6 Million While China is Forecast to Grow at 6.9% CAGR

The Vaccine Storage Equipment market in the U.S. is estimated at US$291.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$268.0 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Vaccine Storage Equipment Market - Key Trends & Drivers Summarized

Why Is Reliable Vaccine Storage Equipment Crucial to Immunization Success Worldwide?

Vaccine storage equipment is a fundamental component of any immunization program, ensuring that vaccines retain their potency and effectiveness from the point of manufacture to the moment they are administered. Vaccines are highly sensitive biological products that require strict temperature control, typically between 2°C and 8°C for most standard vaccines and even colder for certain advanced formulations like mRNA-based vaccines. Without proper storage, vaccines can lose efficacy, rendering immunization efforts ineffective and even dangerous if administered. In large-scale immunization campaigns or routine healthcare delivery, maintaining the cold chain is not just a logistical concern but a matter of public health safety. This makes refrigerators, freezers, cold boxes, and temperature-monitoring devices indispensable across healthcare facilities, pharmacies, research centers, and mobile vaccination units. Global health organizations such as WHO, UNICEF, and Gavi have emphasized the importance of vaccine storage infrastructure, especially in low- and middle-income countries where infrastructure challenges can compromise cold chain integrity. Furthermore, with the increase in global vaccination efforts prompted by COVID-19, the spotlight on vaccine storage has intensified, pushing for improvements in both quality and accessibility of cold chain systems. Proper storage does not only prevent spoilage and financial waste but also ensures that every dose delivered achieves its intended protective effect, making storage equipment as critical as the vaccine itself in the healthcare delivery chain.

How Are Technological Advancements Reshaping the Capabilities of Vaccine Storage Systems?

The evolution of vaccine storage equipment has been significantly influenced by advances in temperature regulation, data monitoring, energy efficiency, and material design. Modern systems now incorporate digital thermostats, automated defrost cycles, and fail-safe alarms to provide precise and uninterrupted temperature control. One of the most notable developments is the integration of continuous temperature monitoring systems that use sensors and cloud-based platforms to alert healthcare providers in real time if storage conditions deviate from prescribed ranges. These features reduce reliance on manual checks and enable faster response to potential equipment failures. Solar-powered refrigerators and battery-supported cold boxes have been transformative in remote or off-grid areas, ensuring stable storage in challenging conditions. In more advanced settings, ultralow temperature (ULT) freezers capable of maintaining temperatures as low as -80°C are supporting the rollout of mRNA vaccines and next-generation biologics. Additionally, vaccine refrigerators are now being designed with user-friendly features such as adjustable shelving, lockable doors for security, and antimicrobial interiors to support hygiene standards. Innovations in insulation materials and compressor efficiency are reducing energy consumption and improving the sustainability of vaccine storage solutions. These technological strides are not only improving performance and reliability but also enabling healthcare systems to meet expanding immunization goals with greater efficiency and fewer resources.

Which Global Markets and Use Cases Are Driving Demand for Vaccine Storage Equipment?

The demand for vaccine storage equipment is rising globally across a wide range of healthcare settings, driven by both high-income nations with sophisticated immunization programs and lower-income countries working to expand vaccine access. In North America and Europe, the need for advanced cold storage is being fueled by the adoption of new vaccine formulations, including those requiring ultracold temperatures, as well as stricter regulatory mandates around vaccine safety. Hospitals, pharmacies, and large health systems in these regions are investing in state-of-the-art refrigeration units that offer precise temperature control, data logging, and connectivity with health information systems. In contrast, countries in Africa, South Asia, and parts of Latin America are focusing on expanding access through more affordable, durable, and low-maintenance equipment suited for decentralized healthcare infrastructure. Programs led by global health organizations are equipping rural clinics and mobile units with solar-powered refrigerators and portable coolers to ensure that vaccines reach underserved populations without spoilage. Additionally, the rapid growth of retail pharmacies and vaccination clinics is boosting the need for compact, countertop vaccine storage units that can function reliably in smaller footprints. The veterinary and research sectors are also important consumers, requiring secure storage of animal vaccines and lab samples under stringent conditions. Seasonal campaigns such as influenza vaccination, travel medicine, and school immunization initiatives further elevate the demand for flexible and scalable storage solutions. These varied use cases across sectors and regions collectively drive a sustained and growing global demand for reliable vaccine storage equipment.

What Are the Main Drivers Fueling Growth in the Vaccine Storage Equipment Market?

The growth in the vaccine storage equipment market is driven by several intersecting forces including global immunization initiatives, regulatory compliance requirements, technological innovation, and increasing awareness of cold chain reliability. One of the most significant drivers is the expansion of national immunization programs and global campaigns to combat vaccine-preventable diseases, which has created widespread demand for safe and scalable storage solutions. The accelerated development and distribution of vaccines in response to COVID-19 acted as a catalyst, highlighting critical gaps in cold chain infrastructure and prompting investments in advanced equipment. Regulatory agencies around the world have tightened storage and documentation standards, requiring healthcare facilities to implement validated equipment with digital monitoring and alert capabilities. The push for equitable vaccine distribution, particularly in underserved regions, is encouraging adoption of off-grid and mobile storage solutions supported by international donors and public-private partnerships. The ongoing development of temperature-sensitive biologics and mRNA-based vaccines is increasing the need for ultracold storage capacity across hospitals, research centers, and logistics providers. Meanwhile, improvements in technology, including IoT-enabled monitoring, solar-powered units, and energy-efficient compressors, are making vaccine storage solutions more accessible and cost-effective. Healthcare digitization trends are also contributing, as facilities seek equipment that can integrate with electronic health records and inventory systems. Together, these factors are driving a robust growth trajectory for the global vaccine storage equipment market, positioning it as an essential enabler of both routine and emergency public health responses.

SCOPE OF STUDY:

The report analyzes the Vaccine Storage Equipment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Cold Boxes, Consumables & Accessories, Foam Pads, Freezer, Monitoring Device, Refrigerator, Vaccine Carriers); Type (Refrigerated Storage, Refrigerated Transport); End-Use (Distributor & Logistics End-Use, Hospitals & Medical Institutes End-Use, Retailer End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â